Skip to main content
QXL Diagnostics
SECOND TRIMESTER SCREENING (15–20 WEEKS) · TRIPLE TEST

Triple Marker Test: Timing, Normal Values and How to Read Your Risk Result

The triple marker test is a second-trimester screening test performed between 15 weeks 0 days and 20 weeks 6 days of pregnancy. It measures Alpha-Fetoprotein (AFP), total hCG, and Unconjugated Oestriol (uE3) in maternal blood to estimate the risk of Down syndrome, Edwards syndrome, and open neural tube defects such as spina bifida.

3 Biomarkers + Risk Software24 HoursSerum
Medically Reviewed by Dr. Shantakumar Muruda, MD Biochemistry, NABL Lead AssessorClinically Reviewed: October 2026
NABL Accredited (MC-6849) Free Home Sample Collection Same-Day Reports on WhatsApp Doctor-Reviewed Results
Department

Prenatal Screening Diagnostics

₹1990₹310036% OFF
Parameters Covered

3 Biomarkers + Risk Software

Sample Specimen

Serum (2 mL)

Report Delivery SLA

24 Hours

Preparation & Fasting Guidelines

💡 Instructions: Ultrasound Gestational Age Required

When Should You Get Tested?

15 weeks 0 days to 20 weeks 6 days pregnancy window (ideal 16–18 weeks)Missed first-trimester double marker screening windowRoutine second-trimester antenatal risk screeningScreening for open spina bifida and neural tube defects

Detailed Clinical Overview

The triple marker test is a second-trimester maternal blood screening test performed strictly between 15 weeks 0 days and 20 weeks 6 days (ideally 16 to 18 weeks). It measures three serum markers: Alpha-Fetoprotein (AFP), total human chorionic gonadotrophin (hCG), and Unconjugated Oestriol (uE3).

Combined with maternal age, weight, exact gestational age dated by ultrasound, and diabetic status, it calculates probability risk figures for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and open neural tube defects (NTDs) such as spina bifida and anencephaly.

If the first-trimester double marker window was missed, the triple marker or quadruple marker test provides essential second-trimester biochemical risk evaluation before the 18–22 week anomaly scan.

Clinical Significance

The triple marker test provides second-trimester risk assessment when the first-trimester screening window (11–13.6 weeks) was missed. Elevated AFP (>2.0 or 2.5 MoM) screens for open neural tube defects (spina bifida, anencephaly) and abdominal wall defects. Low AFP (<0.5 MoM), elevated hCG (>2.0 MoM), and low uE3 (<0.5 MoM) indicate an increased risk of Down syndrome.

Why Get Tested at QXL Diagnostics?

Screens for open neural tube defects (spina bifida & anencephaly) via maternal serum AFP.
Provides second-trimester chromosomal risk screening if the first-trimester double marker window was missed.
Evaluates risk for Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18).
Informs whether high-resolution anomaly ultrasound scan, NIPT, or amniocentesis is indicated.

Reference Ranges — Triple Marker Test: Timing, Normal Values and How to Read Your Risk Result

NABL-validated intervals · Adults · values may vary by age & sex

NormalBorderlineAbnormalReference
Parameter / GroupRangeUnitStatus
AFP (Unaffected Pregnancy)0.5 – 2.0MoMNormal
AFP (Neural Tube Defect Risk)Elevated; risk of spina bifida / anencephaly> 2.0MoMAbnormal
AFP (Down Syndrome Pattern)Decreased level associated with trisomy 21< 0.5MoMAbnormal
Total hCG (Unaffected)0.5 – 2.0MoMNormal
Total hCG (Down Syndrome)Elevated level associated with trisomy 21> 2.0MoMAbnormal
Unconjugated Oestriol (uE3)0.5 – 2.0MoMNormal
Unconjugated Oestriol (uE3 Low)Decreased in Down syndrome & trisomy 18< 0.5MoMAbnormal
Trisomy 21 Risk — Screen Negative< 1 in 250RatioNormal
Trisomy 21 Risk — Screen PositiveHigh risk result — genetic counselling recommended> 1 in 250RatioAbnormal

⚕️ Reference ranges are population-based guidelines. Results must be interpreted in clinical context by a qualified physician. Always consult your doctor before making healthcare decisions.

Frequently Asked Questions

Q: When should the triple marker test be performed?

A: Between 15 weeks 0 days and 20 weeks 6 days of pregnancy, with 16 to 18 weeks being the optimal window. Accurate dating by ultrasound is essential for MoM calculation.

Q: What does the triple marker test screen for?

A: It screens for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and open neural tube defects (such as spina bifida and anencephaly).

Q: What is the difference between double marker and triple marker?

A: Double marker is done in the first trimester (11–13.6 weeks) with PAPP-A, free beta-hCG, and NT scan. Triple marker is done in the second trimester (15–20 weeks) with AFP, total hCG, and uE3, and includes neural tube defect screening.

Q: What does a high AFP result mean on triple marker?

A: An AFP above 2.0 or 2.5 MoM suggests an increased risk of open neural tube defects (spina bifida) or abdominal wall defects. It warrants a targeted high-resolution ultrasound anomaly scan.

Q: Do I need to fast for a triple marker test?

A: No, fasting is not required. What the laboratory requires is accurate gestational age from an ultrasound scan, maternal weight, age, and diabetes status.

Q: What is a normal triple marker result?

A: A calculated risk below 1 in 250 for Down syndrome, and an AFP level below 2.0 MoM for neural tube defects, reported as screen negative.

Q: Is the triple marker or quadruple marker better?

A: The quadruple marker is superior because it adds Inhibin A, improving Down syndrome detection rates to 75–81% compared to approximately 65–70% for the triple marker.

Q: Does a high risk result mean my baby has a birth defect?

A: No. It is a screening probability estimate. Most women with a high-risk result have healthy, normal babies. Further evaluation includes genetic counselling, cell-free DNA (NIPT) screening, a targeted level-II ultrasound, or diagnostic confirmation via amniocentesis.

Q: Can triple marker test be done in twin pregnancies?

A: Yes, but marker levels are higher due to two placentas, requiring specialized twin algorithms. Interpretation carries higher uncertainty than in singletons.

Q: What should I do if my triple marker test is high risk?

A: Consult your obstetrician for genetic counselling. Recommended follow-up steps include a high-resolution level-II anomaly scan at 18–22 weeks, NIPT, or diagnostic amniocentesis.

Doctor-Reviewed Clinical Guide2026 Evidence Update

Personalised Pregnancy Testing in Bengaluru: A Smarter Guide to Prenatal Care

Discover pregnancy blood tests by trimester, triple marker, and gestational diabetes screening with QXL Bengaluru.

Read Guide
₹1990₹310036% OFF

Includes free doorstep home sample collection

Book Home Collection →Or call: +91 9964 639 639
Doctor-Reviewed Content
Dr. Shantakumar Muruda

MD Biochemistry, NABL Lead Assessor · Prenatal Screening Diagnostics

The triple marker test remains a vital second-trimester screen. If a patient missed the first-trimester double marker, the triple or quadruple test provides essential risk calculation for Down syndrome and open neural tube defects before the 18–22 week anomaly scan.

Clinically reviewed · October 2026 · QXL Diagnostics NABL Lab

NABL Quality Guarantees

NABL Accredited (MC-6849)

ISO 15189:2022 quality compliance

Same-Day Digital Reports

Delivered straight to WhatsApp & Email

Free Doorstep Collection

Sterile vacuum containers & cold-chain kits

Triple Marker Test: Timing, Normal Values and How to Read Your Risk Result

₹1990₹310036% OFF
Book Now →